stoxline Quote Chart Rank Option Currency Glossary
  
GlucoTrack, Inc. (GCTK)
0.5342  -0.071 (-11.79%)    02-11 16:00
Open: 0.561
High: 0.5849
Volume: 1,962,553
  
Pre. Close: 0.6056
Low: 0.487
Market Cap: 6(M)
Technical analysis
2025-02-11 4:45:45 PM
Short term     
Mid term     
Targets 6-month :  1.56 1-year :  2.48
Resists First :  1.33 Second :  2.13
Pivot price 0.35
Supports First :  0.05 Second :  0.04
MAs MA(5) :  0.61 MA(20) :  0.28
MA(100) :  0.95 MA(250) :  1.63
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  26.1 D(3) :  27.6
RSI RSI(14): 60.4
52-week High :  4.94 Low :  0.05
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ GCTK ] has closed below upper band by 34.4%. Bollinger Bands are 63.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.59 - 0.59 0.59 - 0.6
Low: 0.48 - 0.48 0.48 - 0.49
Close: 0.53 - 0.54 0.54 - 0.54
Company Description

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Headline News

Tue, 04 Feb 2025
GCTK - GlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan

Tue, 04 Feb 2025
Diabetes Tech Pioneer Glucotrack Raises Fresh Capital: Key Details of $3M Share Offering Revealed - StockTitan

Tue, 04 Feb 2025
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor - Seeking Alpha

Tue, 04 Feb 2025
Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - StockTitan

Thu, 30 Jan 2025
Glucotrack announces 1-for-20 reverse stock split - Investing.com

Thu, 30 Jan 2025
Glucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 155 (M)
Shares Float 4 (M)
Held by Insiders 34.9 (%)
Held by Institutions 0.9 (%)
Shares Short 38 (K)
Shares Short P.Month 24 (K)
Stock Financials
EPS -2.92
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.75
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -157.5 %
Return on Equity (ttm) -541.2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.08
Qtrly Earnings Growth 0 %
Operating Cash Flow -9 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.19
PEG Ratio 0
Price to Book value 0.7
Price to Sales 0
Price to Cash Flow -9.09
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android